Tyson Burghardt

Tyson Burghardt graduated in Medicine from the College of Medicine and Life Sciences at the University of Toledo. After completing residency training in Neurology at Wayne State University, Detroit, Michigan Dr. Burghardt continued at Wayne State University/Detroit Medical Center and completed Fellowship training in Epilepsy and Electroencephalography. Dr. Burghardt is board certified in Neurology, Clinical Neurophysiology and Epilepsy.

Academic Appointments

2012-2019: Assistant Professor, Michigan State University Department of Neurology, 2019-present: Associate Professor, Michigan State University, College of Osteopathic Medicine, Department of Neurology and Ophthalmology
July 2021-present: Chief of the Epilepsy Division of the Department of Neurology and Ophthalmology
July 2021-present: Medical Director of Neurophysiology at UMH-Sparrow Hospital July 2021-present:  Program Director, Epilepsy Fellowship Program
July 2021-present:  Associate Program Director, Clinical Neurophysiology Fellowship Program
July 2016-2021: Associate Program Director, Epilepsy Fellowship Program
July 2016-2021: Program Director, Clinical Neurophysiology Fellowship Program

Education

• M.D., College of Medicine and Life Sciences, University of Toledo 2007

Postdoctoral Training

Residency, Neurology, Wayne State University, Detroit Medical Center 2011 Fellowship, Epilepsy and Electroencephalography, Wayne State University, Detroit Medical Center 2012
Internship, Akron City Hospital 2008

Publications

• Demographic, Regional and Social Predictors of Do Not Resuscitate Order Utilization in Generalized Convulsive Status Epilepticus (GCSE): A National Perspective (P1. 066), Neurology 86.16 Supplement (2016): P1-066.  

• Hyperacute cEEG Attenuation in Aneurysmal Subarachnoid Hemorrhage, Case Reports in Clinical Medicine 5.05 (2016): 165.

• Characteristic EEG rhythms with the use of ketamine in patients with status epilepticus, secondary author, abstract and poster presented at AAN Annual Meeting 2012.

• Crying with sorrow evoked by electrocortical stim- ulation, primary author, Epileptic Disorders 2013 15(1): 72{5.Beyond 24hr vEEG: Relying on Neuropsychological Testing to Better Understand Non-epileptic Seizures, invited paper, Archives of Clinical Neuropsychology 32 (6), 656–666.

• Book Review: MEG: An Introduction to Methods, primary author, Journal of Neurological Sciences 316:1 p. 191, May 2012.

• Characteristic EEG rhythms with the use of ketamine in patients with status epilepticus, secondary author, abstract and poster presented at AAN Annual Meeting 2012.

Abstracts

• A Systematic Literature Review of Substance Use Disorders Involving Antiseizure Medications, poster AES Annual Meeting 2024

• Antiseizure Medication trials measure regression to the mean, poster at AES Annual Meeting 2019

• Case series of perampanel oral load in refractory status epilepticus, poster at AES Annual Meeting 2019Clinical and Radiologic Correlates of Non-Metabolic Triphasic Waves and Epileptiform Activity in Primary Subarachnoid Hemorrhage secondary author, poster presented at American Academy of Neurology Annual Meeting 2013, San Diego, CA.

• Clinical and Radiologic Correlates of Non-Metabolic Triphasic Waves and Epileptiform Activity in Primary Subarachnoid Hemorrhage, poster presented at American Academy of Neurology Annual Meeting 2013, San Diego, CA.

• Nonmetabolic Triphasic Waves and Frontal Rhythmic Slow Activity in Prognosis of Subarachnoid Hemorrhage, primary author, poster presentation at AES Annual Meeting 2012.

Research Interests

Dr. Burghardt’s research interests include EEG signal processing, neurophysiologic monitoring in critical illness, and antiseizure medication clinical trials.

Certifications

ABPN Neurology Certification, ABPN Clinical Neurophysiology Certification, ABPN Epilepsy Certification